144
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19

ORCID Icon, , , , , , , , , , , & show all
Pages 185-195 | Published online: 29 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sri Wahyuni Gayatri, Andi St Fahirah Arsal & Wisudawan. (2023) Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals [Letter]. Journal of Multidisciplinary Healthcare 16, pages 1393-1394.
Read now

Articles from other publishers (2)

Deepak Parchwani, Amit D Sonagra, Sagar Dholariya, Anita Motiani & Ragini Singh. (2023) COVID-19-related liver injury: Focus on genetic and drug-induced perspectives. World Journal of Virology 12:1, pages 53-67.
Crossref
Divya Narayanan & Tanyalak Parimon. (2022) Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus. International Journal of Molecular Sciences 23:14, pages 7702.
Crossref